Tech Company Financing Transactions
Sapience Therapeutics Funding Round
Lambda Fund Management joined a $22 million funding round for Sapience Therapeutics. This venture round was announced on 3/31/2016.
Transaction Overview
Company Name
Announced On
3/31/2016
Transaction Type
Venture Equity
Amount
$22,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
500 Mamaroneck Ave. 320
Harrison, NY 10528
USA
Harrison, NY 10528
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Barry Kappel
VP - R & D
James Rotolo
Browse more venture capital transactions:
Prev: 3/31/2016: Revlocal venture capital transaction
Next: 3/31/2016: Kareo venture capital transaction
Share this article
News on VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs